These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1848420

  • 21. [Randomized trial of cisplatin plus ifosfamide versus cisplatin plus vindesine for non-small cell lung cancer (NSCLC)].
    Nakabayashi T, Miyamoto H, Fujikane T, Shimizu T, Yasuda S, Akita H, Sakai E, Onodera S, Ohsaki Y, Kawakami Y.
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):61-7. PubMed ID: 1309633
    [Abstract] [Full Text] [Related]

  • 22. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.
    Cancer; 1996 Oct 15; 78(8):1701-7. PubMed ID: 8859183
    [Abstract] [Full Text] [Related]

  • 23. Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
    Niederle N, Schütte J, Schmidt CG, Seeber S.
    Cancer Treat Rep; 1984 May 15; 68(5):791-2. PubMed ID: 6327037
    [Abstract] [Full Text] [Related]

  • 24. [A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
    Nishiwaki Y, Nagai K, Kodama T, Nishiyama H, Hojo H, Matsumoto T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec 15; 31 Suppl():203-11. PubMed ID: 8007467
    [Abstract] [Full Text] [Related]

  • 25. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
    Recchia F, Sica G, De Filippis S, Rea S, Frati L.
    Anticancer Res; 1997 Dec 15; 17(5B):3761-5. PubMed ID: 9427776
    [Abstract] [Full Text] [Related]

  • 26. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP, Dafni UG, Malamos NA, Rigatos S, Kouvatseas G, Moschopoulos N.
    Anticancer Res; 1999 Dec 15; 19(4C):3543-8. PubMed ID: 10629650
    [Abstract] [Full Text] [Related]

  • 27. [Evaluation of chemotherapy of unresectable non-small cell lung cancer].
    Hirabayashi M, Tanaka Y, Yoshida H, Nakagawa M, Kawakami K, Mishima M, Kuno K.
    Gan To Kagaku Ryoho; 1992 Jan 15; 19(1):55-60. PubMed ID: 1309632
    [Abstract] [Full Text] [Related]

  • 28. [Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide].
    Höfeler H, Höffken K, Niederle N, Schoetensack B, Wandl U, Kath R, Müller M, Schmidt CG.
    Dtsch Med Wochenschr; 1986 Dec 19; 111(51-52):1961-6. PubMed ID: 3024948
    [Abstract] [Full Text] [Related]

  • 29. Establishment of the standard regimen for non-small-cell lung cancer in Japan.
    Masuda N.
    Oncology (Williston Park); 2001 Jan 19; 15(1 Suppl 1):13-8. PubMed ID: 11221016
    [Abstract] [Full Text] [Related]

  • 30. Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.
    Murray N, Coppin C, Coldman A, Pater J, Rapp E.
    J Clin Oncol; 1994 Nov 19; 12(11):2333-9. PubMed ID: 7964949
    [Abstract] [Full Text] [Related]

  • 31. A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
    Klastersky J, Sculier JP, Ries F, Dabouis G, Libert P, Schmerber J, Thiriaux J, Berchier MC, Bureau G, Van Cutsem O.
    Lung Cancer; 1994 Dec 19; 11(5-6):373-84. PubMed ID: 7704494
    [Abstract] [Full Text] [Related]

  • 32. [Effect of short-term administration of medroxyprogesterone acetate on side reactions of combination chemotherapy with ADR, VDS and CDDP in primary lung cancer].
    Suzuki K, Nogimura H, Wada H, Tomii M, Sugimura H, Horiguchi T, Kimura T, Harada Y.
    Gan To Kagaku Ryoho; 1991 Mar 19; 18(3):431-5. PubMed ID: 1825910
    [Abstract] [Full Text] [Related]

  • 33. Combination chemotherapy with cisplatin, vindesine and mitomycin-C for advanced, inoperable non-small-cell lung cancer.
    Stockler M, Raghavan D, McCaughan BC, Grygiel J, McNeil E, Gianoutsos P, Lee JH.
    Med J Aust; 1992 May 18; 156(10):698-700. PubMed ID: 1377770
    [Abstract] [Full Text] [Related]

  • 34. [A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients].
    González Larriba JL, Alberola V, Lianes P, Panizo A, Carrato A, Muñoz Quintana A, Cardenal F, Gracia JM, Moyano A, Díaz-Rubio E.
    Rev Clin Esp; 1994 Nov 18; 194(11):953-9. PubMed ID: 7846351
    [Abstract] [Full Text] [Related]

  • 35. Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center.
    Joss RA, Bürki K, Dalquen P, Schatzmann E, Leyvraz S, Cavalli F, Ludwig C, Siegenthaler P, Alberto P, Stahel R.
    Cancer; 1990 Jun 01; 65(11):2426-34. PubMed ID: 2159837
    [Abstract] [Full Text] [Related]

  • 36. Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.
    Ohnoshi T, Hiraki S, Ueda N, Fujii M, Machida K, Ueoka H, Kawahara S, Kozuka A, Kiura K, Moritaka T.
    Acta Med Okayama; 1991 Oct 01; 45(5):357-61. PubMed ID: 1661559
    [Abstract] [Full Text] [Related]

  • 37. Phase II study of carboplatin, cisplatin, and vindesine in advanced non-small-cell lung cancer.
    Saito H, Shimokata K, Saka H, Yamamoto M, Ogasawara T, Nomura F, Sakai S, Iwata M, Murate T, Miyachi T.
    Cancer Chemother Pharmacol; 1993 Oct 01; 33(2):154-6. PubMed ID: 8261575
    [Abstract] [Full Text] [Related]

  • 38. A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working Party.
    Klastersky J, Sculier JP, Ries F, Dabouis G, Libert P, Schmerber J, Thiriaux J, Berchier MC, Bureau G, Van Cutsem O.
    Ann Oncol; 1994 Sep 01; 5(7):641-3. PubMed ID: 7993841
    [Abstract] [Full Text] [Related]

  • 39. Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study.
    Honda R, Fujita A, Inoue Y, Asakawa M, Suzuki A.
    Cancer Chemother Pharmacol; 1990 Sep 01; 26(5):373-6. PubMed ID: 2170045
    [Abstract] [Full Text] [Related]

  • 40. Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer. The Eastern Shikoku Lung Cancer Chemotherapy Group.
    Shimizu E, Ogura T, Sone S, Nakayama T, Doi H, Takishita Y, Bando H, Kobayashi M, Kimura K, Sasaki H.
    Oncology; 1993 Sep 01; 50(1):5-9. PubMed ID: 8380634
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.